Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB06702
http://purl.obolibrary.org/obo/dinto_DB06702
|
|---|---|
| Preferred Name | fesoterodine |
| Synonyms |
2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate
C26H37NO3
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | fesoterodine
|
|---|---|
| label | fesoterodine
|
| DBSynonym | feso
|
| ATCCode | G04BD11
|
| Definition | Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.
|
| has effect |
See more
See less
|
| DBSalt | fesoterodine fumarate
|
| has pharmacological target | |
| type | |
| InChIKey | InChIKey=DCCSDBARQIPTGU-HSZRJFAPSA-N
|
| is metabolised by | |
| blocks | |
| AHFScode | 12:08.08
|
| Synonym |
2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate
C26H37NO3
|
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Fesoterodine
Drugs.com:http://www.drugs.com/cdi/fesoterodine.html
RxList:http://www.rxlist.com/toviaz-drug.htm
PubChem Compound:6918558
ChemSpider:5293755
PubChem Substance:99443256
National Drug Code Directory:54868-6175-0
PharmGKB:PA165958376
See more
See less
|
| CASRN | 286930-03-8
|
| prefixIRI | obo2:dinto_DB06702
|
| is transported by | |
| SMILES | CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
|
| may interact with | |
| InChI | InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1
|
| DBBrand | toviaz
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |